Facebook Twitter LinkedIn YouTube Instagram

To navigate the following site navigation expect to utilize the tab key to move through items sequentially. The spacebar or enter keys can be utilized to interact with items that open sub-navigation.

The next tab will be the search box toggle. Hit enter to open the search, focus will automatically shift to the search bar. Type a letter into the search input and suggested results will appear.

Drug

Mesenchymal stem cell

Status:

Phase 1

Condition:

Lung Transplant

Intervention Type:

Intravenous (IV) Injection

Funder Type:

Organization | University

Drug Details

Mesenchymal stem cells derived from allogeneic, bone marrow.

Study Purpose

To assess the safety and feasibility of mesenchymal stem cells therapy in patients with transplant related bronchiolitis obliteran syndrome (BOS)

This drug has no clinical trials actively recruiting patients at this time.